Latest updates from the American Society of Hematology (ASH) Annual Meeting 2019

View the Latest Updates

EDUCATIONAL SESSIONS

THE 2019 ASCO® ANNUAL MEETING

Watch a selection of recorded educational sessions from the 2019 ASCO® Annual Meeting, covering haematological malignancies*

 

2019 ASH® MEETING WEBCASTS

Watch your peers presenting some of the top educational sessions from the ASH® Annual Meeting and 2019 ASH® Meeting on Hematologic Malignancies
 

MORE FROM JANSSEN HAEMATOLOGY

View clinical data and practical information
on DARZALEX® in multiple myeloma patients

Explore the data >

One tablet, once a day. Simplifying the
treatment experience for your patients

Explore the data >

REFERENCES

  1. NICE (2019). Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma [ID974] – Final Appraisal Determination document. Available at https://www.nice.org.uk/guidance/gid-ta10174/documents/final-appraisal-determination-document. Last accessed December 2019
  2. ©NHS. Cancer drugs fund list. Available at https://www.england.nhs.uk/publication/national-cancer-drugs-fund-list/. Last accessed December 2019
  3. ©NICE (2018). Daratumumab for multiple myeloma [ID933]- Final Appraisal Determination document. Available at https://www.nice.org.uk/guidance/ta510. Accessed December 2019.
April 2020 | CP-134557